Optimal planning of phase II/III programs for clinical trials with multiple endpoints.

MLA

Kieser, Meinhard, et al. “Optimal Planning of Phase II/III Programs for Clinical Trials with Multiple Endpoints.” Pharmaceutical Statistics, vol. 17, no. 5, Sept. 2018, pp. 437–57. EBSCOhost, https://doi.org/10.1002/pst.1861.

APA

Kieser, M., Kirchner, M., Dölger, E., & Götte, H. (2018). Optimal planning of phase II/III programs for clinical trials with multiple endpoints. Pharmaceutical Statistics, 17(5), 437–457. https://doi.org/10.1002/pst.1861

Chicago

Kieser, Meinhard, Marietta Kirchner, Eva Dölger, and Heiko Götte. 2018. “Optimal Planning of Phase II/III Programs for Clinical Trials with Multiple Endpoints.” Pharmaceutical Statistics 17 (5): 437–57. doi:10.1002/pst.1861.